Articles with "ecog acrin" as a keyword



Photo from wikipedia

Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805

Sign Up to like & get
recommendations!
Published in 2018 at "Quality of Life Research"

DOI: 10.1007/s11136-018-1817-4

Abstract: PurposeWhile quality of life measures may be used to assess meaningful change and group differences, their scaling and validation often rely on a single occasion of measurement. Using the 13-item FACIT-Fatigue questionnaire at three timepoints,… read more here.

Keywords: facit fatigue; change; measurement; factor ... See more keywords
Photo from wikipedia

CNS Involvement in AML at Diagnosis is Rare and does not Affect Response or Survival: Data from 11 ECOG-ACRIN Trials.

Sign Up to like & get
recommendations!
Published in 2021 at "Blood advances"

DOI: 10.1182/bloodadvances.2021004999

Abstract: Central nervous system (CNS) involvement in newly diagnosed acute myeloid leukemia (AML) patients is rare and systematic data regarding outcome are scarce. This retrospective study summarized data from 11 consecutive ECOG-ACRIN clinical trials for newly… read more here.

Keywords: cns involvement; newly diagnosed; diagnosis; involvement aml ... See more keywords

Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review

Sign Up to like & get
recommendations!
Published in 2023 at "Cancers"

DOI: 10.3390/cancers15092561

Abstract: Simple Summary Immune checkpoint inhibitors (ICIs) can cause granulomatous and sarcoid-like lesions (GSLs) in several organs, and limited data existing that adequately inform the incidence and severity. This study examined GSL incidence in patients with… read more here.

Keywords: swog s1404; ecog acrin; acrin e1609; pd1 ... See more keywords